Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$182.27M
Total Bought:
$51.60M
Total Sold:
$60.70M
Net Transaction:
-$9.11M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)92,500115,000+22,500$56.89M$68.06M37.34%+$11.18M
Rhythm Pharmaceuticals, Inc.(RYTM)727,982907,240+179,258$40.75M$48.06M26.37%+$7.30M
Revolution Medicines, Inc.(RVMD)210,000392,011+182,011$9.19M$13.86M7.61%+$4.68M
Soleno Therapeutics Inc70,027172,902+102,875$3.15M$12.35M6.78%+$9.21M
Disc Medicine, Inc.(IRON)185,000243,311+58,311$11.73M$12.08M6.63%+$349.0K
Protagonist Therapeutics Inc0175,184+175,184$0$8.47M4.65%+$8.47M
Stoke Therapeutics, Inc.(STOK)305,387730,717+425,330$3.37M$4.86M2.67%+$1.49M
Septerna, Inc.(SEPN)0824,878+824,878$0$4.78M2.62%+$4.78M
Kymera Therapeutics, Inc.(KYMR)77,535136,605+59,070$3.12M$3.74M2.05%+$619.6K
TScan Therapeutics, Inc.(TCRX)1,755,9872,017,650+261,663$5.34M$2.78M1.53%-$2.55M
Cidara Therapeutics Inc196,949104,380-92,569$5.11M$2.25M1.23%-$2.87M
Corcept Therapeutics Incorporated(CORT)05,000+5,000$0$571.1K0.31%+$571.1K
Immunocore Holdings plcADS(IMCR)09,011+9,011$0$267.4K0.15%+$267.4K
Rapt Therapeutics Inc0109,830+109,830$0$134.0K0.07%+$134.0K
Atyr Pharma Inc432,5610-432,561$1.57M$0—-$1.57M
Avadel Pharmaceuticals Plc1,004,7900-1,004,790$10.56M$0—-$10.56M
Axsome Therapeutics, Inc.(AXSM)174,7690-174,769$14.79M$0—-$14.79M
Cytokinetics, Incorporated(CYTK)20,0000-20,000$940.8K$0—-$940.8K
Phathom Pharmaceuticals, Inc.(PHAT)2,274,1570-2,274,157$18.47M$0—-$18.47M
Pliant Therapeutics, Inc.(PLRX)535,4940-535,494$7.05M$0—-$7.05M
Trevi Therapeutics, Inc.(TRVI)1,084,1350-1,084,135$4.47M$0—-$4.47M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q1 2025 | TickerTrail